Spectral AI appoints founder Dr. J. Michael DiMaio to board; top shareholders extend lock-up 180 days

Spectral AI, Inc.

Dr. J. Michael DiMaio appointed to board effective Feb 7, 2024, filling vacancy left by Michael Murphy.
DiMaio is a founder, former CEO/Chairman (2011-2020), and a cardiac surgeon at Baylor Scott & White.
He has authored nearly 500 publications, led $150M+ in research funding, oversees 120+ clinical trials.
Two largest stockholders (DiMaio and Spangenberg) holding ~45% of shares extended lock-up for additional 180 days.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. J. Michael DiMaio

director

MDAI · Spectral AI, Inc.

Effective: 2024-02-12
Filed: February 12, 2024, 6:59 PM ET

The board of directors (the “ Board ”) of Spectral AI, Inc., a Delaware corporation (the “ Company ”) appointed Dr. J. Michael DiMaio to serve as director on the Company’s Board, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. J. Michael DiMaio was appointed as director at Spectral AI, Inc..

Action: appointed
Role: director

Exact text from the filing

The board of directors (the “ Board ”) of Spectral AI, Inc., a Delaware corporation (the “ Company ”) appointed Dr. J. Michael DiMaio to serve as director on the Company’s Board, effective immediately.

View on SEC.gov

Spectral AI, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-012284

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.